ZBIO in the 13F filings
Zenas Biopharma Inc · CUSIP 98937L105
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 18
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 0 listed it in both
- Shares listed
- 14,673,855
- combined, among listed positions
- Reported value
- $302m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +4,985,650.
Managers listing ZBIO in Q1 2026
18 of 18 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 9,082,000 shares now+1,377,745
- AllianceBernstein LPexisting position · 897,321 shares now+878,971
- Woodline Partners LPnew position · 590,525 shares now+590,525
- Marshall Wace LLPexisting position · 501,928 shares now+494,828
- Balyasny Asset Management LLCexisting position · 667,070 shares now+473,917
Reductions
- Invesco Ltdexisting position · 113,479 shares now-74,489
- Voloridge Investment Management LLCexisting position · 77,493 shares now-55,946
- AQR Capital Management LLCexisting position · 50,971 shares now-27,249
- T. Rowe Price Associates Incexisting position · 357,266 shares now-11,982
New positions and exits
New (3)
Exited (3)
- Point72 Asset Management LPwas $9.2m
- Janus Henderson Group Ltdwas $287k
- Brevan Howard Capital Management LPwas $224k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2024 | 1 | $634k | 1 | 0 |
| Q1 2026 | 1 | $12m | 14 | 7 |
| Q2 2026 | 1 | $15m | 17 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ZBIO and LLY →ZBIO and JNJ →ZBIO and VRTX →Choose a stock to compare with ZBIO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ZBIO, latest filings →Back to the 13F Explorer →